Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

236 ARTÍCULOS , VIENDO DEL 166 AL 180

On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer's Disease

Kriska J, Hermanova Z, Knotek T, Tureckova J, Anderova M.

Int J Mol Sci. 2021 Sep 7;22(18):9689. doi: 10.3390/ijms22189689.

Should We Open Fire on Microglia? Depletion Models as Tools to Elucidate Microglial Role in Health and Alzheimer's Disease

Romero-Molina C, Navarro V, Jimenez S, Muñoz-Castro C, Sanchez-Mico MV, Gutierrez A, Vitorica J, Vizuete M.

Int J Mol Sci. 2021 Sep 8;22(18):9734. doi: 10.3390/ijms22189734.

A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease

Senda M, Ishii K, Ito K, Ikeuchi T, Matsuda H, Iwatsubo T, Iwata A, Ihara R, Suzuki K, Kasuga K, Ikari Y, Niimi Y, Arai H, Tamaoka A, Arahata Y, Itoh Y, Tachibana H, Ichimiya Y, Washizuka S, Odawara T, Ishii K, Ono K, Yokota T, Nakanishi A, Matsubara E, Mori H, Shimada H.

J Prev Alzheimers Dis. 2021;8(4):495-502. doi: 10.14283/jpad.2021.37.

The Impact of Ageing on the CNS Immune Response in Alzheimer's Disease

Chee SEJ, Solito E.

Front Immunol. 2021 Sep 17;12:738511. doi: 10.3389/fimmu.2021.738511. eCollection 2021.

PET Imaging of Neuroinflammation in Alzheimer's Disease

Zhou R, Ji B, Kong Y, Qin L, Ren W, Guan Y, Ni R.

Front Immunol. 2021 Sep 16;12:739130. doi: 10.3389/fimmu.2021.739130. eCollection 2021.

Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services-part 2 of 6

Ranson JM, Rittman T, Hayat S, Brayne C, Jessen F, Blennow K, van Duijn C, Barkhof F, Tang E, Mummery CJ, Stephan BCM, Altomare D, Frisoni GB, Ribaldi F, Molinuevo JL, Scheltens P, Llewellyn DJ; European Task Force for Brain Health Services.

Alzheimers Res Ther. 2021 Oct 11;13(1):169. doi: 10.1186/s13195-021-00895-4.

Electroencephalography as a Non-Invasive Biomarker of Alzheimer's Disease: A Forgotten Candidate to Substitute CSF Molecules?

Monllor P, Cervera-Ferri A, Lloret MA, Esteve D, Lopez B, Leon JL, Lloret A.

Int J Mol Sci. 2021 Oct 8;22(19):10889. doi: 10.3390/ijms221910889.

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Siafarikas N, Kirsebom BE, Srivastava DP, Eriksson CM, Auning E, Hessen E, Selbaek G, Blennow K, Aarsland D, Fladby T.

Sci Rep. 2021 Oct 13;11(1):20375. doi: 10.1038/s41598-021-99794-9.

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum

Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier F, Karikari TK, Hourregue C, Cognat E, Dumurgier J, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Salvadó G, Shekari M, Operto G, Gispert JD, Minguillon C, Fauria K, Kollmorgen G, Suridjan I, Zimmer ER, Zetterberg H, Molinuevo JL, Paquet C, Rosa-Neto P, Blennow K, Suárez-Calvet M; Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer’s and Families (ALFA) study, and BioCogBank Paris Lariboisière cohort.

JAMA Neurol. 2021 Dec 1;78(12):1471-1483. doi: 10.1001/jamaneurol.2021.3671.

Crosstalk between epigenetics and mTOR as a gateway to new insights in pathophysiology and treatment of Alzheimer's disease

Agarwal D, Kumari R, Ilyas A, Tyagi S, Kumar R, Poddar NK.

Int J Biol Macromol. 2021 Dec 1;192:895-903. doi: 10.1016/j.ijbiomac.2021.10.026. Epub 2021 Oct 15.

Current research status of blood biomarkers in Alzheimer's disease: Diagnosis and prognosis

Feng L, Li J, Zhang R.

Ageing Res Rev. 2021 Dec;72:101492. doi: 10.1016/j.arr.2021.101492. Epub 2021 Oct 19.

Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer's Disease Patients: How to Measure and Use It

Squitti R, Ventriglia M, Granzotto A, Sensi SL, Rongioletti MCA.

Curr Alzheimer Res. 2021;18(7):533-545. doi: 10.2174/1567205018666211022085755.

A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach

Tan MS, Cheah PL, Chin AV, Looi LM, Chang SW.

Comput Biol Med. 2021 Dec;139:104947. doi: 10.1016/j.compbiomed.2021.104947. Epub 2021 Oct 14.

Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer's Disease

Huang YL, Lin CH, Tsai TH, Huang CH, Li JL, Chen LK, Li CH, Tsai TF, Wang PN.

Int J Mol Sci. 2021 Oct 9;22(20):10903. doi: 10.3390/ijms222010903.

Alzheimer's disease associated with Down syndrome: a genetic form of dementia

Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M.

Lancet Neurol. 2021 Nov;20(11):930-942. doi: 10.1016/S1474-4422(21)00245-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias